RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT BETWEEN NEOSE TECHNOLOGIES, INC. AND NOVO NORDISK A/SResearch, Development and License Agreement • March 10th, 2008 • Neose Technologies Inc • Medicinal chemicals & botanical products • Pennsylvania
Contract Type FiledMarch 10th, 2008 Company Industry JurisdictionThis RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (“Agreement”), is dated as of November 2, 2007 (the “Effective Date”), between Neose Technologies, Inc., a Delaware corporation (“Neose”), and Novo Nordisk A/S, a Danish corporation (“Novo”).
Portions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. Such...Research, Development and License Agreement • March 10th, 2008 • Neose Technologies Inc • Medicinal chemicals & botanical products • Pennsylvania
Contract Type FiledMarch 10th, 2008 Company Industry JurisdictionThis RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (“Agreement”), is dated as of November 2, 2007 (the “Effective Date”), between Neose Technologies, Inc., a Delaware corporation (“Neose”), and Novo Nordisk A/S, a Danish corporation (“Novo”).
AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT AMONG NEOSE TECHNOLOGIES, INC. AND NOVO NORDISK A/S AND NOVO NORDISK HEALTH CARE AG DATED AS OF OCTOBER 31, 2006Research, Development and License Agreement • March 16th, 2007 • Neose Technologies Inc • Medicinal chemicals & botanical products • Pennsylvania
Contract Type FiledMarch 16th, 2007 Company Industry JurisdictionThis AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (“Agreement”), is dated as of October 31, 2006 (the “Restatement Date”), among Neose Technologies, Inc., a Delaware corporation (“Neose”), and Novo Nordisk A/S, a Danish corporation, and Novo Nordisk Health Care AG, a Swiss Corporation (collectively, “Novo”).